423 related articles for article (PubMed ID: 27311104)
1. Increased serum brain-derived neurotrophic factor levels following electroconvulsive therapy or antipsychotic treatment in patients with schizophrenia.
Li J; Ye F; Xiao W; Tang X; Sha W; Zhang X; Wang J
Eur Psychiatry; 2016 Aug; 36():23-8. PubMed ID: 27311104
[TBL] [Abstract][Full Text] [Related]
2. Brain-Derived neurotrophic factor (BDNF) plasma level increases in patients with resistant schizophrenia treated with electroconvulsive therapy (ECT).
Shahin O; Gohar SM; Ibrahim W; El-Makawi SM; Fakher W; Taher DB; Abdel Samie M; Khalil MA; Saleh AA
Int J Psychiatry Clin Pract; 2022 Nov; 26(4):370-375. PubMed ID: 35192426
[TBL] [Abstract][Full Text] [Related]
3. Plasma BDNFs level initially and post treatment in acute mania: comparison between ECT and atypical antipsychotic treatment and healthy controls.
Karamustafalioglu N; Genc A; Kalelioglu T; Tasdemir A; Umut G; Incir S; Akkuş M; Emul M
J Psychopharmacol; 2015 Aug; 29(8):898-902. PubMed ID: 25827643
[TBL] [Abstract][Full Text] [Related]
4. Changes in serum levels of brain-derived neurotrophic factor with electroconvulsive therapy and pharmacotherapy and its clinical correlates in male schizophrenia patients.
Akbas I; Balaban OD
Acta Neuropsychiatr; 2022 Apr; 34(2):99-105. PubMed ID: 34924073
[TBL] [Abstract][Full Text] [Related]
5. Serum brain-derived neurotrophic factors in Taiwanese patients with drug-naïve first-episode schizophrenia: Effects of antipsychotics.
Chiou YJ; Huang TL
World J Biol Psychiatry; 2017 Aug; 18(5):382-391. PubMed ID: 27643618
[TBL] [Abstract][Full Text] [Related]
6. Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment.
Pirildar S; Gönül AS; Taneli F; Akdeniz F
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):709-13. PubMed ID: 15276697
[TBL] [Abstract][Full Text] [Related]
7. Brain-derived neurotrophic factor and electroconvulsive therapy in a schizophrenic patient with treatment-resistant paranoid-hallucinatory symptoms.
Martinotti G; Ricci V; Di Nicola M; Caltagirone C; Bria P; Angelucci F
J ECT; 2011 Mar; 27(1):e44-6. PubMed ID: 21206369
[TBL] [Abstract][Full Text] [Related]
8. Neurotrophic factor changes are essential for predict electroconvulsive therapy outcome in schizophrenia.
Li J; Zhang X; Tang X; Xiao W; Ye F; Sha W; Jia Q
Schizophr Res; 2020 Apr; 218():295-297. PubMed ID: 31932174
[TBL] [Abstract][Full Text] [Related]
9. Acute and subsequent continuation electroconvulsive therapy elevates serum BDNF levels in patients with major depression.
Vanicek T; Kranz GS; Vyssoki B; Fugger G; Komorowski A; Höflich A; Saumer G; Milovic S; Lanzenberger R; Eckert A; Kasper S; Frey R
Brain Stimul; 2019; 12(4):1041-1050. PubMed ID: 31000384
[TBL] [Abstract][Full Text] [Related]
10. The Influence of Electroconvulsive Therapy (ECT) on Brain-Derived Neurotrophic Factor (BDNF) Plasma Level in Patients with Schizophrenia-A Systematic Review and Meta-Analysis.
Szota AM; Kowalewska B; Ćwiklińska-Jurkowska M; Dróżdż W
J Clin Med; 2023 Sep; 12(17):. PubMed ID: 37685795
[TBL] [Abstract][Full Text] [Related]
11. Remission of depression following electroconvulsive therapy (ECT) is associated with higher levels of brain-derived neurotrophic factor (BDNF).
Freire TF; Fleck MP; da Rocha NS
Brain Res Bull; 2016 Mar; 121():263-9. PubMed ID: 26892396
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the effectiveness of rehabilitation of people diagnosed with schizophrenia using clinical tools, psychological tests, QEEG, and the brain-derived neurotrophic factor (BDNF).
Markiewcz RA; Markiewicz-Gospodarek A; Kozioł M; Szulecka B; Olajossy M; Plech T
Psychiatr Pol; 2019 Dec; 53(6):1275-1292. PubMed ID: 32017817
[TBL] [Abstract][Full Text] [Related]
13. Brain-derived neurotrophic factor as a biomarker for cognitive recovery in acute schizophrenia: 12-week results from a prospective longitudinal study.
Zhang Y; Fang X; Fan W; Tang W; Cai J; Song L; Zhang C
Psychopharmacology (Berl); 2018 Apr; 235(4):1191-1198. PubMed ID: 29392373
[TBL] [Abstract][Full Text] [Related]
14. Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients.
Bocchio-Chiavetto L; Zanardini R; Bortolomasi M; Abate M; Segala M; Giacopuzzi M; Riva MA; Marchina E; Pasqualetti P; Perez J; Gennarelli M
Eur Neuropsychopharmacol; 2006 Dec; 16(8):620-4. PubMed ID: 16757154
[TBL] [Abstract][Full Text] [Related]
15. ECT-induced brain plasticity correlates with positive symptom improvement in schizophrenia by voxel-based morphometry analysis of grey matter.
Wang J; Tang Y; Curtin A; Xia M; Tang X; Zhao Y; Li Y; Qian Z; Sheng J; Zhang T; Jia Y; Li C; Wang J
Brain Stimul; 2019; 12(2):319-328. PubMed ID: 30473477
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and clinical predictors of response to combined ECT and antipsychotic therapy in patients with treatment-resistant schizophrenia and dominant negative symptoms.
Pawełczyk T; Kołodziej-Kowalska E; Pawełczyk A; Rabe-Jabłońska J
Psychiatry Res; 2014 Dec; 220(1-2):175-80. PubMed ID: 25129562
[TBL] [Abstract][Full Text] [Related]
17. Randomized, double-blind, sham-controlled trial to evaluate the efficacy and tolerability of electroconvulsive therapy in patients with clozapine-resistant schizophrenia.
Melzer-Ribeiro DL; Napolitano IC; Leite SA; Alencar de Souza JA; Vizzotto ADB; Di Sarno ES; Fortes M; Gomes ML; de Oliveira GM; Avrichir BS; Talib LL; Correll CU; Elkis H
Schizophr Res; 2024 Jun; 268():252-260. PubMed ID: 38151432
[TBL] [Abstract][Full Text] [Related]
18. Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics.
Xiu MH; Hui L; Dang YF; Hou TD; Zhang CX; Zheng YL; Chen DC; Kosten TR; Zhang XY
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1508-12. PubMed ID: 19720106
[TBL] [Abstract][Full Text] [Related]
19. Brain-derived neurotrophic factor serum and plasma levels in the treatment of acute schizophrenia with olanzapine or risperidone: 6-week prospective study.
Kudlek Mikulic S; Mihaljevic-Peles A; Sagud M; Bajs Janovic M; Ganoci L; Grubisin J; Kuzman Rojnic M; Vuksan Cusa B; Bradaš Z; Božina N
Nord J Psychiatry; 2017 Oct; 71(7):513-520. PubMed ID: 28671000
[TBL] [Abstract][Full Text] [Related]
20. Association between the novel seizure quality index for the outcome prediction in electroconvulsive therapy and brain-derived neurotrophic factor serum levels.
Kranaster L; Hellweg R; Sartorius A
Neurosci Lett; 2019 Jun; 704():164-168. PubMed ID: 30978454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
